Biologic’s area new class of drugs used to suppress parts of the autoimmune system which causes inflammation in the body. This inflammation causes the body to attack the areas of the body targeted by autoimmune diseases, chiefly Rheumatoid Arthritis, Psoriatic arthritis, Psoriasis, and Ankylosing Spondylitis among others (“Biologic treatments for rheumatoid arthritis,” 2015).

The number of drugs in this class is expanding rapidly and includes many well-advertised. The reason for this is that the number of diseases treated by these drugs continues to expand at a high rate. At the time of this writing Actemra a drug used to treat Rheumatoid Arthritis has entered Phase III trials for stopping disease progression in Type 1 diabetics (Joshua, 2015). Increasingly these drugs continue to cross into the treatment of other diseases either caused or made worse by an autoimmune disease response.

References

Biologic treatments for rheumatoid arthritis. (2015). Retrieved March 31, 2015, from https://www.rheumatology.org/Practice/Clinical/Patients/Medications/Biologic_Treatments_for_Rheumatoid_Arthritis/

Joshua, L. (2015, March 15, 2015). Current research into a cure for type-1 diabetes. Retrieved March 31, 2015, from http://cureresearch4type1diabetes.blogspot.com/2015/03/tocilizumab-actemra-starts-phase-ii.html

Here are a few more resources for Biologic Therapy Arthritis:

rheumatology-rad arthritis-rad